What schedule is Dextroamphetamine classified under?

Dextroamphetamine is classified as a Schedule II controlled substance under the Controlled Substances Act. This categorization is based on its potential for abuse and dependence. Schedule II drugs are substances that have a high potential for abuse, which may lead to severe psychological or physical dependence. Dextroamphetamine, used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy, fits this classification due to its effectiveness and potential for misuse.

The Schedule II designation means that while it has accepted medical uses, stringent regulations apply to its prescription and distribution. For example, prescriptions for Schedule II drugs cannot be refilled; they must be written and signed by a prescriber. This level of control reflects the necessity of balancing access to effective medications with the need to minimize the risks associated with their misuse.

In contrast, substances classified under other schedules, such as Schedule I, have no accepted medical use, while those in Schedule III and IV have a lower potential for abuse and dependence, leading to different regulations regarding their prescription and dispensing.